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Background: Psychosocial interventions for substance
dependence have demonstrated efficacy. However, the
mechanisms by which specific intervention strategies
exert their effect have not been clearly identified.
Objective: This study investigated the prospective
relationships between two psychological processes, an
attentional bias toward cocaine stimuli and beliefs
about the consequences of cocaine use, and treatment
outcome. Method: Twenty-five cocaine-dependent
participants enrolled in a 6-month outpatient
treatment program that included voucher incentives
for abstinence. All participants were asked to
complete two implicit assessment procedures, a Drug
Stroop protocol and an Implicit Relational
Assessment Procedure (IRAP), as well as explicit
measures of cocaine craving and the consequences of
cocaine use, prior to beginning treatment. Pearson’s
correlation coefficients tested the prospective
relationships between treatment outcome and the
implicit and explicit assessments. Results: Stronger
implicit beliefs about the positive effects of cocaine
use prior to treatment were associated with poorer
treatment outcome when an escalating
voucher-incentive program was in place. Further, an
attentional bias for cocaine-related stimuli was
associated with better treatment outcome when an
escalating voucher-incentive program was removed.
No association between cocaine use beliefs and
treatment outcome was found when beliefs were
measured with self-report instruments. Conclusions
and scientific significance: These findings highlight
the potential utility of performance-based measures
for delineating the psychological mechanisms
associated with variation in response to treatment for
drug dependence.
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INTRODUCTION
Psychosocial interventions for substance use disorders
can facilitate behavior change (1). However, treatment-
specific mechanisms have yet to be identified (2), which
suggests that treatments may exert their influence through
pathways common to different intervention strategies.
The actions of attending and deriving relations have been
implicated in the development and maintenance of behav-
ioral disorders (3,4), including drug dependence (5,6),
and correspondingly may be two overarching psychologi-
cal mechanisms by which counseling-based interventions
influence drug use behavior.
Substance users are more likely to attend to stimuli
related to their substance of choice compared to nonsub-
stance users (5), and relatively stronger attentional biases
toward drug-specific stimuli are associated with worse
treatment outcome (7,8). Incentive-motivational theories
of drug use postulate that attentional biases toward drug-
associated cues are primarily driven by reward-based
mechanisms (9). In line with this perspective, counsel-
ing strategies have been developed to help individuals
become more attentive to the circumstances surrounding
their substance use (e.g., identify people, places, things,
or triggers) in order to implement alternative behavioral
responses (10,11) or employ attentional training exercises
to shift attending behavior away from drug-related stimuli
(i.e., reduce attentional bias) to disrupt the incentive-
motivational process promoting drug use (12). In contrast,
the presence of an attentional bias may be influenced by
an individual’s goals to avoid further substance use (5).
That is, the stimuli may not initiate an appetitive process
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but promote an avoidance or fear-based process. This
notion is supported by the findings demonstrating an
attentional bias among cocaine-dependent participants
relatively motivated to avoid substance use (i.e., seeking
treatment) but not among nontreatment-seeking cocaine-
dependent individuals (13). Thus, the presence of an
attentional bias under these circumstances may highlight
an important shift in the motivational processes called
forth in the presence of drug-related stimuli.
Drug and alcohol users derive relationships between
their substance use and the occurrence of specific con-
sequences, which can differ in both degree and valence.
These differences predict variation in substance-related
attentional bias (14) as well as substance use in nonde-
pendent (15) and dependent populations (16). Further, the
degree to which individuals derive relationships between
their substance use and negative consequences prior to
beginning treatment predicts reduced use in both alco-
hol (17) and cocaine (18) abusers. These findings suggest
that effective motivational interviewing and cognitive
behavioral therapy (CBT) counseling strategies, such as
building a discrepancy and working through a functional
analysis, respectively, may build upon preestablished
beliefs about the negative effects of substance use rather
than develop new, or modify, preestablished relationships.
Overall, it is believed that counseling strategies that can
influence the types of stimuli individuals attend to and the
relations individuals derive between their substance use
and its consequences can facilitate a better understanding
of the circumstances promoting drug use, provide a con-
text for altering the positive incentive value of substance
use, and help reduce the frequency of drug use behavior.
This study investigated the prospective relationships
between an attentional bias toward cocaine stimuli,
the derived relations between cocaine use and positive
and negative consequences, and the treatment outcome.
Understanding the specific processes promoting atten-
tional biases and how derived relations between substance
use and its consequences impact attentional biases and
treatment outcome may help identify individual level fac-
tors that account for the significant variation in treatment
response (19). Since there is evidence that the associa-
tion between substance use outcome beliefs and treatment
outcome may be dependent on the assessment meth-
ods employed (20), this study utilized both explicit and
implicit measures of cocaine effect beliefs.
METHOD
Participants
The study was approved by the Institutional Review
Board (IRB) of the New York State Psychiatric Institute.
All participants were active cocaine users seeking treat-
ment at Columbia University’s Substance Treatment and
Research Service (STARS) as part of a study investigating
the neurobiological correlates of behavior change dur-
ing treatment for cocaine dependence (21). Participants
responded to print and radio advertisements distributed
throughout the New York City area. The screening eval-
uation included the Structured Clinical Interview for
DSM-IV (SCID-IV) disorders, an independent psychi-
atric evaluation, and a medical exam. Individuals were
eligible to participate if they were between the ages of
21 and 45, met criteria for a current DSM-IV diagnosis
of cocaine dependence, and could demonstrate 14 days
of abstinence from cocaine prior to the neurobiological
assessment procedures. Participants who could not pro-
vide 14 days of abstinence from cocaine prior to initiating
the study were offered a 2-week inpatient stay to satisfy
this requirement. Exclusion criteria included currently
meeting criteria for other Axis I DSM-IV disorders, life-
time criteria for dependence on a psychostimulant other
than cocaine, reporting the current use of psychotropic
medication or the use of opiates, sedative-hypnotics, or
cannabis more than twice per week, and/or the presence
of severe medical (e.g., hypertension, active hepatitis) or
neurological illnesses.
Twenty-five participants completed a baseline assess-
ment session, met inclusion criteria, and gave informed
consent to participate in the study. On average, the sam-
ple was 37 years of age (SD = 7.1), predominantly male
(88%), and was racially mixed (36% Caucasian, 28%
African American, 24% Hispanic, and 3% other). A total
of 16% of the participants reported not graduating high
school, 48% reported having a high-school or equivalent
diploma, and 36% reported having more than a high-
school education. On average, cocaine was first used at
the age of 22 years (SD = 6.7 years) and was being
used on 13 of the 30 days prior to screening (SD = 9.0
days). Approximately 35% reported intranasal cocaine
use, 15% reported smoking cocaine, and 47% reported
using both administration routes. One participant was
not able to read and thus did not complete a majority
of the assessment instruments. Five individuals did not
complete the Implicit Relational Assessment Procedure
(IRAP) and self-report instruments but did complete the
Drug Stroop assessment. All assessments (IRAP, Drug
Stroop task, Cocaine Effects Questionnaire (CEQ), and
Cocaine Craving Questionnaire (CCQ)) were conducted
during the first week of treatment prior to beginning the
counseling sessions.
Treatment Program
The 24-week outpatient program used the Community
Reinforcement Plus Vouchers Treatment Approach (22).
The counseling program had two phases (i.e., weeks 1–12
and 13–24). During Phase I participants were scheduled
to attend the clinic thrice per week. Participants met with
their counselor 1 hour on two of these visits to develop
the behavioral skills needed to decrease cocaine use and
increase alternative nondrug-use behaviors.
Urine samples were collected on each visit. Partici-
pants earned voucher points worth $.25 for every sample
that tested negative for cocaine. Participants also received
a $10 bonus for every three consecutive cocaine-free
urine samples. The number of voucher points earned
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started at 10 and escalated by 5 points with each con-
secutive cocaine metabolite-free urine. Missed clinic
appointments and cocaine-positive urine samples reset
the voucher earnings to the starting value, although par-
ticipants did not lose the amount of points they had
earned prior to the reset. Participants could reclaim their
voucher point maximum by providing five consecutive
cocaine-free urines. All urine samples were collected
under the observation of a staff member and were imme-
diately tested (chromatographic immunoassay) for the
presence or absence of benzoylecgonine using the stan-
dard National Institute on Drug Abuse (NIDA) cutoff
(300 ng/mL). All participants received immediate feed-
back on the urine analysis and their cumulative voucher
earnings at each clinic visit. A maximum of $997.50
in vouchers could be earned for submitting cocaine-free
urines on all 36 scheduled treatment visits over the course
of 12 weeks.
During Phase II, participants were scheduled to attend
the clinic twice per week and met once per week with
their counselor for approximately 1 hour. The escalating
voucher system was discontinued; instead a New York
State lottery ticket was earned for each cocaine-free urine.
Counseling sessions were audiotaped and reviewed by
a supervising psychologist for fidelity and supervisory
purposes.
Measures
Treatment Outcome
The primary outcome variables were the following: (i)
the percentage of therapy visits attended (total number
attended/total number scheduled), (ii) the total amount of
voucher earnings earned (dollar amounts for Phase I; the
number of lottery tickets earned during Phase II), and (iii)
the total percentage of urines testing negative for cocaine.
Since the voucher incentives and the frequency of ther-
apy sessions differed over the course of treatment, the
outcomes were calculated separately for each phase of
treatment. Entering Phase II of the treatment was also
coded (i.e., yes or no) and analyzed as an outcome vari-
able. Scheduled urine samples that were not collected
were coded as cocaine positive.
Drug Stroop
The Drug Stroop task requires participants to respond
to the color (blue, red, green, yellow) of a drug-related
or neutral (nondrug-related) word by pressing the same
colored key on a response pad as quickly and accu-
rately as possible (7). For each trial, a fixation-cross
appeared in the center of the monitor screen for 1000
ms and was then replaced by a colored word. Each word
remained on the screen until the participant responded or
for a maximum time period of 6000 ms. Two blocks of
50 trials, for a total of 100 words (20 words for each
for heroin, cocaine, marijuana, mixed drug, and neutral
word groups), followed 16 practice trials. A 5-minute
rest period was programmed into the task following the
completion of the first block of 50 words. The primary
measure was interference from cocaine-related words,
which was calculated for each participant by subtract-
ing their average response time on neutral words from
their average response time to the cocaine words. Posi-
tive values (i.e., slower responding to the cocaine words)
are interpreted as reflecting an attentional bias toward
cocaine-related stimuli.
Implicit Relational Assessment Procedure
The IRAP (23,24) was employed as an implicit measure
of an individual’s beliefs about the positive and nega-
tive consequences of cocaine use. The IRAP was utilized
because it offers numerous advantages over other implicit
measurement procedures. In terms of the present study,
it provided an assessment of four different implicit rela-
tions regarding cocaine use (see below), thus offering a
nonrelativistic assessment of implicit beliefs unlike other
implicit assessment procedures. The IRAP also has the
potential to assess the flexibility with which individu-
als hold particular beliefs about cocaine use by requiring
participants to respond in both a consistent and an incon-
sistent manner across all presented items.
The IRAP is a computer-based task in which partic-
ipants were asked to respond quickly and accurately in
ways that may be similar or dissimilar to their established
beliefs about cocaine use. Data collection coincided with
the availability of an early version of the IRAP pro-
gram (v2005). Participants were exposed to two practice
blocks and six test blocks. Each block presented the
same 12 trials. For each trial, a category label was pre-
sented at the top of the screen (the words “With Cocaine”
or “No Cocaine”), one of 12 target phrases in the cen-
ter (i.e., Positive Phrases: I am sexier, I am in control,
I am friendlier, I am nicer, I am talkative, I have no
pain; Negative Phrases: I am jumpy, I am paranoid, I
am alone, I am tense, I am mean, I want to fight), and
the two response options, “true” and “false”, in the bot-
tom corners (see Figure 1). All the stimuli were presented
simultaneously and remained visible until the participant
made a response. Selecting a correct term removed all
the stimuli from the screen for 400 ms and the next
trial was then presented. Selecting the incorrect term pro-
duced a red “X”, which remained on the screen until the
participant selected the correct response term.
A correct response was defined in terms of whether the
participant was completing a consistent block or inconsis-
tent block of trials. During a consistent block, participants
were required to respond to the four trial types in the
following manner: “with cocaine” trials as having posi-
tive consequences (e.g., “with cocaine” – “I am sexier” –
true) and no negative consequences (e.g., “with cocaine”
– I am tense- false) and “no cocaine” trials as hav-
ing negative consequences (e.g., “no cocaine” – “I am
alone” – true) and no positive consequences (e.g., “no
cocaine” – “I am friendlier” – false). During an inconsis-
tent block the feedback contingencies were reversed and
participants were required to respond to “with cocaine”
trials as having no positive consequences (e.g., “with
cocaine” – “I am sexier” – false) and having negative
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(A) (C)
(B) (D)
No cocaine
Negative consequence
(e.g., I am alone)
Select “d” for
True
Select “k” for
False
Anti-cocainePro-cocaine
With cocaine 
Negative consequence
(e.g., I am alone)
Select “d” for
True
Select “k”for
False
Pro-cocaineAnti-cocaine
No cocaine
Positive consequence
(e.g., I am friendly)
Select “d” for
True
Select “k”for
False
Anti-cocaine Pro-cocaine
With cocaine
Positive consequence
(e.g., I am friendly)
Select “d” for
True
Select “k” for
False
Anti-cocainePro-cocaine
FIGURE 1. The four IRAP trial types. The category label (“With Cocaine” or “No Cocaine”), target phrase (either positive effects (e.g.,
I am friendly) or negative effects (e.g., I am alone)), and response options (True and False) appeared simultaneously on each trial. Arrows
with the superimposed text boxes indicate which responses were deemed pro-cocaine or anti-cocaine (boxes and arrows did not appear on
the screen). (A) With Cocaine Positive, (B) With Cocaine Negative, (C) No Cocaine Negative, and (D) No Cocaine Positive.
Note: IRAP, Implicit Relational Assessment Procedure.
consequences (“with cocaine” – I am tense – true) and
“no cocaine” trials as having positive consequences (e.g.,
“no cocaine” – “I am friendlier” – true) and no negative
consequences (e.g., “no cocaine” – “I am alone” – false).
Thus, each block containing the four trial types (Figure 1)
could be characterized as being pro-cocaine (consistent
blocks) or anti-cocaine (inconsistent blocks) depending
on the feedback contingencies in place. The pro-cocaine
block (defined here as consistent-relations) was presented
first to half the participants and the anti-cocaine (defined
here as inconsistent-relations) block was presented first
to the other half. The target phrases for each item were
taken from items most strongly related to the positive and
negative cocaine effect factors on the CEQ (18).
For the first two practice blocks, participants were
informed that it was a practice phase and the experimenter
remained in the room to answer any questions during
this part of the assessment and observe the participants’
engagement with the task. After completing the two prac-
tice blocks all participants moved into the test phase of
the assessment irrespective of their performance during
the practice blocks. The location (bottom right and bot-
tom left) of the two response options for each item (e.g.,
“true” and “false”) varied for every item presentation. The
time that elapsed from the presentation of the item until
a correct response was recorded (response latency) was
used to calculate the D-IRAP scores.
Similar to other implicit assessment methods it is
hypothesized that the average response latencies should
be shorter for the blocks of items that are consis-
tent with an individual’s beliefs compared to blocks
that are inconsistent with their beliefs. Thus, individ-
uals who relate cocaine use to positive consequences,
or not using cocaine to negative consequences, should
respond quicker on the IRAP trials that were catego-
rized as “pro-cocaine” and slower on the IRAP trials that
were categorized as “anti-cocaine”. An overall index, a
D-IRAP score, based on differences in response times
between the pro-cocaine and anti-cocaine trials across the
six test blocks, was calculated for each of the four trial
types and for the overall assessment (22). The D-IRAP
score is an adaptation of the D-algorithm scoring for
the Implicit Association Test (25) and functions to char-
acterize the difference in performance between the two
response sets (pro-cocaine and anti-cocaine) while min-
imizing the impact of factors such as age, motor skills,
and/or cognitive ability on latency data. A positive D-
IRAP score reflects relatively stronger pro-cocaine beliefs
(i.e., or slower responding during the inconsistent test
blocks compared to the consistent test blocks). In con-
trast, a negative D-IRAP score reflects relatively stronger
anti-cocaine beliefs. In accordance with recommended
D-IRAP calculation procedures, one participant’s data
were eliminated because more than 10% of their response
latencies were less than 300 ms.
To assess the internal consistency of the IRAP, test
trials were designated as odd or even depending on
their order of presentation. Two D-scores, one based on
even trials and one based on odd trials, were calculated
for the four individual trial types (With Cocaine Posi-
tive; With Cocaine Negative; No Cocaine Positive, and
No Cocaine Negative), the two category labels: “With
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Cocaine” and “No Cocaine”, and the overall D-score.
Split-half correlations between the D-scores calculated
from the odd and even trials applying Spearman–Brown
corrections were calculated (n = 19 for all reliabil-
ity analyses). Reliabilities for the individual trial types
were as follows: With Cocaine Positive, r = .35; With
Cocaine Negative, r = −.15; No Cocaine Negative,
r = .47; and No Cocaine Positive, r = .34. The poor
reliability for the With Cocaine Negative trials was
due to two significant outliers on the even trials (the
split-half correlation was r = .44 with the partici-
pants removed). Reliabilities for the two category labels
and overall score were adequate: “With Cocaine” trials
r = .74; “No Cocaine” trials r = .49; and overall D-score
r = .85.
Cocaine Effects Questionnaire
The CEQ (18) is a 33-item self-report instrument assess-
ing a participant’s belief in the short-term positive and
negative consequences of their own cocaine use. Each
item is rated along a 7-point Likert scale with the anchors
of 1 (never) and 7 (always). Items load on four positively
valenced factors (enhanced well-being, sexual enhance-
ment, social facilitation, and pain reduction) and three
negatively valenced factors (social withdrawal, aggres-
sion, and increased tension). The global positive (the
average of the four positive valence factors; Cronbach’s
alpha = .93 for this sample) and negative effect (the aver-
age of the three negatively valenced factors; Cronbach’s
alpha = .81) scales were used for the present study.
Cocaine Craving Questionnaire
The CCQ (26) is a 45-item self-report instrument devel-
oped to assess a general level of cocaine craving and
urges experienced over the preceding week (e.g., I want
cocaine). Items are rated along a 7-point Likert scale with
the anchors of 1 (Strongly Disagree) and 7 (Strongly
Agree). The CCQ total score, an averaging of the
responses across the 45 items, was used for the present
study (Cronbach’s alpha = .62).
RESULTS
Treatment Outcome
Treatment and assessment outcomes for the entire sam-
ple are presented in Table 1. Over half the participants
completed the first phase of treatment and approximately
a third completed the full 6-month treatment program.
On average, participants attended a majority of treatment
sessions and demonstrated a little more than a month of
continued abstinence during Phase I. The attendance rate
and proportion of cocaine negative urines were reduced
during Phase II, the point at which the escalating voucher
system was removed.
TABLE 1. Treatment outcome, explicit, and implicit measures and associated 95% confidence intervals for cocaine-
dependent participants beginning the outpatient treatment program.
Variable Mean (SD) (95% CI)
Treatment outcomes
CRA + vouchers (weeks 1–12)
Voucher earnings $351.80 (385.49) ($200.7; $502.0)
Proportion of therapy sessions attended .64 (.33) (.51; .77)
Proportion of urines negative for cocaine (missing
coded as positive)
.55 (.36) (.41; .69)
No. of consecutive urines testing negative 14.4 (13.2) (9.2; 19.6)
Completing voucher segment (%) 56.0 (n = 14)
CRA + lottery (weeks 13–24)
Proportion of therapy sessions attended .30 (.34) (.17; .43)
Proportion of urines negative for cocaine (with
missing coded as positive).
.24 (.35) (.10; .38)
No. of consecutive urines testing negative 3.2 (5.3) (1.2; 5.3)
Completing 6-month trial (%) 32.0 (n = 8)
Performance measures (implicit)
Drug Stroop (cocaine interference) 19.77 ms (120.0 ms) (−28.2 ms; 67.8 ms)
Overall D-IRAP (test response times) −.16 (.34) (−.31; −.01)
IRAP trial type (D-scores)
With Cocaine Positive −.19 (.41) (−.37; −.01)
With Cocaine Negative −.23 (.46) (−.44; −.02)
No Cocaine Positive −.16 (.47) (−.37; .05)
No Cocaine Negative −.07 (.46) (−.28; .14)
Self-report measures (explicit)
Negative cocaine effects 4.10 (1.10) (3.64; 4.56)
Positive cocaine effects 3.83 (1.32) (3.27; 4.39)
CCQ total 3.49 (1.34) (3.23; 3.75)
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Self-Report Assessments
On average, participants’ endorsement of negative and
positive consequences of cocaine use were of sim-
ilar magnitude (i.e., the 95% CIs overlap) prior to
beginning treatment. Further, ratings for the cocaine-
craving questionnaire during the first week of treatment
indicated a moderate level of craving at the start of
treatment.
Task Performance
On average, participants demonstrated a positive inter-
ference score on the Drug Stroop task. However, there
was considerable variability around the group mean
and the confidence interval included zero, which sug-
gested that an attentional bias toward cocaine-related
words was not demonstrated in this sample. On the
IRAP task, an overall significant negative D-IRAP was
demonstrated. Negative D-scores were also demonstrated
across all four trial types. The negative D-score indi-
cates participants responded quicker to the items pre-
sented during inconsistent blocks (anti-cocaine) com-
pared to items presented in the consistent blocks (pro-
cocaine). This pattern suggests stronger “anti-cocaine”
beliefs relative to “pro-cocaine” beliefs. It should be
noted that there was considerable variability in both
the IRAP and Drug Stroop performances. Approxi-
mately 50% of the participants demonstrated relatively
stronger “pro-cocaine beliefs” (i.e., a positive D-IRAP)
and an attentional bias to cocaine stimuli (i.e., a pos-
itive interference score; slower responding to cocaine
words).
Relationship between Explicit (Self-Report) and
Implicit (Performance-Based) Measures and Treatment
Outcome
The correlations assessing the prospective relationship
between the explicit and the implicit measures with treat-
ment outcome are presented in Table 2. D-IRAP scores
were inversely and moderately correlated with treat-
ment outcomes during the first 12 weeks of treatment.
This relationship was strongest for the “With Cocaine
Positive” and the “With Cocaine Negative” trial types.
These results indicate participants who exhibited rela-
tively faster reaction times to trials reinforcing a rela-
tionship between cocaine use and positive consequences
(e.g., “with cocaine” – “I am sexier” – “true”) and trials
denying a relationship between cocaine use and neg-
ative consequences (“with cocaine” – “I am tense” –
“false”) demonstrated lower treatment attendance rates
and proportions of cocaine-free urines. Stroop Interfer-
ence, CEQ, and CCQ scores were not correlated with
treatment outcome during Phase I of treatment.
Stroop Interference scores were positively and moder-
ately correlated with the three treatment outcome mea-
sures for the second phase of treatment. This indicates
that participants who exhibited a relatively stronger atten-
tional bias to cocaine stimuli subsequently were more
likely to enter Phase II of the treatment and demonstrated
higher treatment attendance rates and a greater proportion
of cocaine-free urines. In addition, greater cocaine use in
Phase II of treatment was associated with a stronger pro-
cocaine belief on the “With Cocaine Positive” IRAP trial
types. Similar trends were noted for the “With Cocaine
Negative” trials indicating participant responses more
TABLE 2. Pearson’s correlation coefficients testing the relationship between treatment outcomes and self-report (explicit)-based and
performance (implicit)-based measures.
Treatment Weeks 1–12 Treatment Weeks 13–24
Measures
Voucher
earnings
Visits
attended
(%)
UA
cocaine
negative
(%)
Entered
Phase II1
Number
of lottery
ticket
Visits
attended
(%)
UA
cocaine
negative
(%)
Self-report
Negative cocaine effects2 .06 .03 .12 −.20 −.21 −.27 −.27
Positive cocaine effects2 .03 −.01 .04 .09 .09 .09 .09
CCQ total .25 .16 .21 .24 .21 .11 .18
Performance measures
D-IRAP scores by trial type3
With Cocaine Positive −.46∗ −.58∗∗ −.56∗ −.42 −.45 −.37 −.46∗
With Cocaine Negative −.38 −.48∗ −.48∗ −.37 −.37 −.24 −.36
No Cocaine Positive −.03 −.19 −.18 −.13 −.13 −.08 −.13
No Cocaine Negative −.47∗ −.23 −.40 −.01 −.01 .18 −.01
Overall scores
D-IRAP3 −.43 −.47∗ −.52∗ −.29 −.30 −.16 −.30
Drug Stroop (interference) .11 .28 .18 .46∗ .48∗ .51∗ .49∗
Notes: IRAP, Implicit Relational Assessment Procedure; UA, Urine Analysis.
Data show the relationships among cocaine-dependent participants beginning outpatient treatment.
∗∗p < .01, ∗p < .05. n sizes vary due to missing data.
1Point-biserial coefficient; 2n = 21; all other comparisons, n = 24; 3n = 19.
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TABLE 3. Pearson’s correlation coefficients testing the relation-
ships among the explicit assessments and implicit measures.
Self-report measures
Negative
cocaine
effects
Positive
cocaine
effects CCQ
Drug
Stroop
IRAP trials1
With Cocaine
Positive
−.07 .00 .11 −.55∗∗
With Cocaine
Negative
−.26 .07 −.22 −.35
No Cocaine
Positive
−.11 .13 .15 −.04
No Cocaine
Negative
.02 .19 −.11 .03
Overall
D-IRAP
−.14 .14 −.02 −.28
Drug Stroop2 .25 .02 −.14 –
Notes: IRAP, Implicit Relational Assessment Procedure.
Explicit assessments include cocaine effects and craving; implicit
measures include Drug Stroop and IRAP.
∗∗p < .01; 1n = 19; 2n = 21.
consistent with an absence of negative consequences were
associated with worse treatment outcome during Phase II
of treatment. The overall IRAP, CEQ, and CCQ, scores
were not correlated with treatment outcome during the
second treatment phase.
Relationship between the Explicit and Implicit
Measures
Table 3 presents the correlations among the explicit
(CEQ and CCQ) and implicit measures (Drug Stroop
and IRAP). There was a significant negative associa-
tion between D-IRAP for the “With Cocaine Positive”
trial type and Stroop interference scores. This rela-
tionship indicates that relatively stronger anti-cocaine’
beliefs (slower responding on items that reinforce pos-
itive consequences of cocaine use) was associated with
a greater attentional bias toward cocaine-related stimuli.
The explicit measures were not associated with either the
Stroop or IRAP performances. Additional analyses (not
shown) controlling for the frequency of cocaine use in the
month before treatment did not alter either the magnitude
or the direction of the reported findings.
DISCUSSION
This study found that cocaine-dependent treatment seek-
ers, as a group, derived stronger relations between
cocaine use and negative outcomes then cocaine use
and positive outcomes when assessed with the IRAP,
an implicit assessment procedure. Further, as a group,
cocaine-dependent participants did not demonstrate an
attentional bias for cocaine-related stimuli. However,
individual differences on the IRAP and Drug Stroop mea-
sures were prospectively related to treatment outcome
while differences on the self-report, or explicit, measures
were not. Derived relations between cocaine use and pos-
itive consequences and cocaine use and the absence of
negative consequences were associated with poorer reten-
tion and worse treatment outcome when an escalating
voucher-incentive program for cocaine abstinence was in
place. Furthermore, a similar pattern of associations were
noted when a nonescalating contingency management
protocol was in place. A relatively stronger attentional
bias to cocaine stimuli was also associated with longer
treatment retention and better treatment outcome when a
nonescalating contingency management protocol was in
place.
The finding that a cocaine-associated attentional bias
was associated with better treatment outcome was incon-
sistent with studies that suggest attentional biases may
be prognostic of a poor treatment response (7,8). The
present results suggest individuals who are more reactive
to cocaine-related stimuli may be more likely to benefit
from counseling strategies that aim to identify triggers
and develop alternative coping responses. However, few
studies have directly investigated the clinical implications
of attentional biases; thus, continued research in this area
is needed to more fully delineate how attentional biases
may influence behavior change. Moreover, parameters of
the present study may have contributed to the inconsis-
tent findings. Participants in this study were assessed after
14 days of abstinence. Previous studies have included
treatment seekers who were actively using at the time of
treatment enrollment, which may have selected partici-
pants with more severe cocaine dependence. This study
also employed an escalating voucher-incentive protocol
for cocaine-free urines at the beginning of treatment.
Voucher incentives can exert a strong effect on drug use
behavior and may have counteracted the deleterious effect
of having a strong attentional bias toward cocaine stim-
uli in the beginning of treatment. Also, the nonescalating
voucher protocol was implemented in the second half
of the treatment program, thus the effects of the esca-
lating voucher system and participant attrition may have
influenced the demonstrated relationship between Stroop
performance and treatment outcome during Phase II of
treatment. Further research is needed to highlight how
specific elements of a treatment protocol alter the prog-
nostic significance of different cognitive processes, such
as an attentional bias to cocaine stimuli.
Responding more quickly to IRAP items relating
cocaine use to both the presence of positive consequences
and the absence of negative consequences (i.e., “pro-
cocaine” beliefs) was associated with poorer treatment
outcome in the context of an escalating voucher-incentive
program that reinforced abstinence from cocaine. Further,
self-report assessments of craving and the beliefs about
the negative and positive consequences of cocaine use did
not correlate with treatment outcome in either phase of
treatment. These findings are consistent with other inves-
tigations demonstrating a link between substance use
outcome beliefs and treatment response (17,18). How-
ever, unlike previous studies, the relationship was only
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demonstrated with an indirect measure of an individual’s
belief about the effects of cocaine use. Evidence sug-
gests that direct and indirect assessment procedures do
not always covary (27) and each may have a different
relation with drug use (15). Implicit measures may offer
a platform for assessing the strength of beliefs about drug
use that reduces the influence of demand characteristics.
Moreover, implicit assessment procedures may highlight
the role of psychological processes (e.g., motivation) that
are not accessible by more explicit assessment methods.
Thus, as the current findings suggest, the use of implicit
assessment procedures can provide important prognostic
information. Future studies are needed to better under-
stand the processes captured by different measurement
procedures, how they may influence treatment outcome
in the context of different therapy platforms, and the
malleability of these processes in response to specific
intervention techniques.
It is interesting to note that there was an inverse
association between the IRAP and Drug Stroop per-
formances. A stronger attentional bias was associated
with IRAP responding that was more consistent with an
“anti-cocaine” perspective on the “With Cocaine Posi-
tive” trials. Specifically, a stronger attentional bias was
associated with IRAP responding relating cocaine use to
the absence of positive consequences. This demonstrated
relationship is more consistent with the view that threat –
or distress – based processes may drive an attentional bias
among treatment seekers (13). In contrast, the incentive-
motivational theory would predict a positive relationship
between an attentional bias toward cocaine stimuli and
IRAP responding indicative of “a pro-cocaine” belief
(the presence of positive consequences, the absence of
negative consequences). However, these are preliminary
findings and further studies investigating the motivational
and cognitive processes driving the Stroop interference
effects among treatment seekers are needed.
This study had several limitations. The small sample
size prohibited multivariate modeling of the relationship
between treatment outcome and Drug Stroop and IRAP
performances and may have also increased the chances
of not detecting associations that did exist (i.e., Type II
error). For example, the correlations between the IRAP
trial types and Phase II treatment outcome measures were
of a notable magnitude but failed to reach statistical sig-
nificance. The relatively low reliabilities on the IRAP trial
types may have mitigated against finding stronger rela-
tionships between these measures and treatment response.
However, the overall D-score did demonstrate a stronger
reliability and demonstrated a similar pattern of rela-
tionships with treatment outcome and explicit measures.
The primary objective of the parent study (21) was
to investigate the neurobiological correlates of behav-
ior change during a treatment episode. As such long-
term post-treatment assessments were not completed.
Thus, the present study cannot address the relationship
between implicit cognition and long-term post-treatment
outcomes. Further investigation of this relationship would
be an important addition to the literature. Moreover, while
the IRAP effect has been replicated (24) and compares
well with other indirect measures (e.g., IAT), it is a fairly
new procedure that continues to be researched. Despite
these limitations this preliminary investigation indicates
that (i) performance-based measures of derived relations
and an attentional bias may identify important relation-
ships between specific cognitive and verbal processes and
treatment outcome and (ii) the parameters of the treatment
platform employed may influence which psychological
factors relate to behavior change.
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